SmartKem, Inc. (SMTK): Nasdaq/NYSE listing notice — SmartKem receives Nasdaq bid price deficiency notice; equity rule delisting appeal pending

SmartKem, Inc.

Received Nasdaq notice on March 5, 2026 for failing minimum bid price of $1.00 over 30 consecutive trading days.
Has 180 days (until September 1, 2026) to regain compliance by closing at $1.00+ for 10 consecutive days.
Company currently has less than $5M in stockholders' equity, which may affect eligibility for a second grace period.
Previously received delisting notice on Feb 12, 2026 for equity rule non-compliance; hearing requested and pending.
May consider a reverse stock split to cure bid price deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

SmartKem, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

March 5, 2026, SmartKem, Inc. (the “Company”) received notice (the “Notification Letter”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency conti

View on SEC.gov

Browse all listing & compliance notices →

SmartKem, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-026443

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.